CMS确定2027年韦戈维、特雷莱吉及其他13种药物在Medicare中的价格
CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs
生命科学资讯
生物技术与制药领域的最新动态
诺华获准对年长患者使用脊髓性肌萎缩基因疗法
Novartis wins approval to use SMA gene therapy in older patients
吉利德收购一项临床前癌症研究项目
Gilead scoops up a preclinical cancer program
大型药企员工如何评价他们的CEO？
How do Big Pharma employees rate their CEOs?
科伦、默克力推ADC药物作为肺癌一线治疗新选择
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
拜耳实验性止血剂在卒中预防试验中取得胜利
Bayer’s experimental blood-thinner notches trial win in stroke prevention
#Asundexian Phase#prevention Asundexian#study results#clinical setbacks#Phase
Novo Nordisk的GLP-1在受到关注的阿尔茨海默病研究中missed目标
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
#Novo Nordisk#watched Alzheimer#misses goal#heart health#combat neurodegeneration
FDAสอบ询了Takeda的罕见病药物的影响，患者死亡
FDA probes effects of Takeda rare disease drug after patient death
#FDA probes#Takeda rare#neutralizing antibodies#probes effects#rare disease
Here is the translation: 比奥根与Versant支持的生物技术公司达成协议，扩展免疫组合 (Bǐ ào gēn yǔ Véisǎnt zhī chí zhù de shēng wù jì shù gōng sī dá chéng què yì, kuò zhǎn mì nǎo zǔ hé)
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
#Dayra Therapeutics#Versant-backed biotech#portfolio Newly#Newly launched#launched Dayra
APOE4和CRISPR正在重新定义阿尔茨海默症风险
APOE4 and CRISPR are reframing Alzheimer’s Risk
#reframing Alzheimer#CRISPR brings#slowing Alzheimer#brings hope#CRISPR
艾利利 Laboratories 成为第一家价值一万亿美元的制药公司
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
#Eli Lilly#drugmaking peers#pharmaceutical company#success developing#developing medicines
FDA 探索加速药物制造商谈判的新计划；Bezos关联AI初创公司筹集6000万美元
FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M
#quick clarifications#FDA tests#drugmaker talks#speed drugmaker#agency staff
GSK，Anaptysbio对Jemperli收入进行诉讼
GSK, Anaptysbio sue each other over Jemperli revenue
#Jemperli revenue#royalty business#cancer immunotherapy#Anaptysbio sue#Anaptysbio seeks
(Ai zuò chéng wēi xìng de zuì chū yào fù huì bù gōng gǎn MS)
A brain biotech’s top drug fails against MS
#Contineum Therapeutics#Therapeutics dipped#late Thursday#piqued Johnson#brain biotech
（Modernahù bǎo jiàng 5亿美金 lifeline，瞄准2028年平衡）
Moderna secures $1.5B lifeline as it looks to break even in 2028
#Moderna secures#day event#disease programs#analyst day#invest revenue
罗氏药丸在早期乳腺癌治疗中取得进展——生物制药动态
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
罗氏多发性硬化症片剂在后期研究中取得成效——BioPharma Dive
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
罗氏携手AI专家研发新型脑部药物——BioPharma Dive报道
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
#Roche taps#BioPharma Dive#Dive Roche#brain drugs#Dive
罗氏斥资24亿美元收购89bio，进军MASH领域——BioPharma Dive
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
#BioPharma Dive#Roche dives#Dive Roche#MASH#deal
Illumina拟以最高4.25亿美元收购SomaLogic——BioPharma Dive报道
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
#BioPharma Dive#buy SomaLogic#deal worth#Dive Illumina#Dive